참고문헌
- Hepler CD and Strand LM. Opportunity and responsibility in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
- Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacist-2003. Pharmacotherapy 2003; 23:1210-25. https://doi.org/10.1592/phco.23.10.1210.32752
- Bond CA and Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy 2006;26:735-47. https://doi.org/10.1592/phco.26.6.735
- Bond CA and Raehl CL. Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy. Pharmacotherapy 2006;26: 369-78.
- Gray DR, Garabedian-Ruffalo SM, Chretien SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm 1985;19:575-80. https://doi.org/10.1177/106002808501900716
- McGivney MS, Meyer SM, Duncan-Hewitt W, et al. Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc 2007;47:620-28. https://doi.org/10.1331/JAPhA.2007.06129
- American Pharmacists Association and National Association of Chain Drug Stores Foundation. Medication management therapy in pharmacy practice: Core elements of an MTM service model (version 2.0). J Am Pharm Assoc 2008;48:341-53. https://doi.org/10.1331/JAPhA.2008.08514
- McBane SE, Dopp AL, Abe A, et al. Collaborative drug therapy management and comprehensive medcation manangement-2015. Pharmacotherapy 2015;35:e39-e50. https://doi.org/10.1002/phar.1563
- Bluml BM. Definition of medication therapy manangement: development of professionwide consensus. J Am Pharm. Assoc 2005;45:566-72. https://doi.org/10.1331/1544345055001274
- American College of Clinical Pharmacy (ACCP). Standards of practice for clinical pharmacists. Pharmacotherapy 2014;34:794-7. https://doi.org/10.1002/phar.1438
- Duckworth W, Abraira C, Mortiz T, et al. VADT Investigators. Glucose control and vascular complications in verterans with type 2 diabetes. N Engl J Med 2009;360:129-39. https://doi.org/10.1056/NEJMoa0808431
- Patel A, MacMahon S, Chalmers J, et al. ADVANCE Collaborative Group. Intesive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72. https://doi.org/10.1056/NEJMoa0802987
- Gerstein HC, Miller ME, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes Study Group. Effect of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. https://doi.org/10.1056/NEJMoa0802743
- Al Mazroui NR, Kamal MM, Ghabash NM, Yacout TA, Kole PL, McElnay JC. Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 2009; 67:547-57. https://doi.org/10.1111/j.1365-2125.2009.03391.x
- Chan CW, Siu SC, Wong CK, Lee VW. A pharmacist care program: positive impact on cardiac risk in patients with type 2 diabetes. J Cardiovasc Pharmacol Ther 2012;17:57-64. https://doi.org/10.1177/1074248410396216
- Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manag Care 2005;11:253-60.
- Chung WW, Chua SS, Lai PS, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence 2014;8:1185-94.
- Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005;28:771-76. https://doi.org/10.2337/diacare.28.4.771
- Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ 2011;37:801-12. https://doi.org/10.1177/0145721711423980
- Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci 2011;16:43-49.
- Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan. J Manag Care Pharm 2012;18:516-26.
- Mahwi TO, Obied KA. Role of the pharmaceutical care in the management of patients with type 2 diabetes mellitus. Int J Pharm Sci Res 2013;4:1363-69.
- Mourao AO, Ferreira WR, Martins MA, et al. Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial. Int J Clin Pharm 2013;35:79-86. https://doi.org/10.1007/s11096-012-9710-7
- Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med 2005;118:276-84. https://doi.org/10.1016/j.amjmed.2004.09.017
- Scott DM, Boyd ST, Stephan M, Augustine SC, Reardon TP. Outcomes of pharmacist-managed diabetes care services in a community health center. Am J Health Syst Pharm 2006;63:2116-22. https://doi.org/10.2146/ajhp060040
- Simpson SH, Majumdar SR, Tsuyuki RT, Lewanczuk RZ, Spooner R, Johnson JA. Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2011;34:20-26. https://doi.org/10.2337/dc10-1294
- Sriram S, Chack LE, Ramasamy R, Ghasemi A, Ravi TK, Sabzghabaee AM. Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus. J Res Med Sci 2011;16(Suppl 1):S412-18.
- Wishah RA, Al-Khawaldeh OA, Albsoul AM. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: randomized controlled trial. Diabetes Metab Syndr 2015;9:271-76. https://doi.org/10.1016/j.dsx.2014.09.001
- Plaster CP, Melo DT, Boldt V, et al. Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up. Braz J Pharm Sci 2012;48:435-46. https://doi.org/10.1590/S1984-82502012000300010
- Malathy R, Narmadha M, Ramesh S, Alvin JM, Dinesh BN. Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India. J Young Pharm 2011;3:65-72. https://doi.org/10.4103/0975-1483.76422
- Korean Diabetes Association. Diabetes Fact Sheet in Korean 2016. Available from: http://www.diabetes.or.kr/pro/news/admin.php?code=admin&number=1331&mode=vi ew
- Smith MA, Nigro SC. The patient-centered medical home. In: Chessman CC, Richardson M, et al, eds. Pharmacotherapy Self-Assessment Program 7th ed. Science and practice of pharmacotherapy. Lenexa, KS: American College of Clinical Pharmacy 2011: 87-102.
- MedicalTimes News. 2014-10-15.[Internet] Available at http://www.medicaltimes.com/Users4/News/newsView.html?ID=1092591. accessed 25 Mar, 2017.
- Nichols-English G. Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc 2012;40:475-85.
- Conrad P. The meaning of medications: Another look at compliance. Soc Sci Med 1985;20:29-37. https://doi.org/10.1016/0277-9536(85)90308-9
- Monte SV, Slazak EM, Albenese NP, et al. Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. J Am Pharm Assoc 2009;49:200-8. https://doi.org/10.1331/JAPhA.2009.08160
- Cranor CW, Bunting BA, Christensen DB. The Asheville Project: Long-term clijncial and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:173-84.